As of 2024-12-12, the EV/EBITDA ratio of Editas Medicine Inc (EDIT) is -0.31. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EDIT's latest enterprise value is 68.44 mil USD. EDIT's TTM EBITDA according to its financial statements is -222.64 mil USD. Dividing these 2 quantities gives us the above EDIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 16.9x | 16.0x |
| Forward P/E multiples | 15.6x - 17.8x | 15.8x |
| Fair Price | (40.97) - (44.47) | (41.59) |
| Upside | -2158.7% - -2334.9% | -2189.8% |
| Date | EV/EBITDA |
| 2024-12-06 | -0.36 |
| 2024-12-05 | -0.28 |
| 2024-12-04 | -0.31 |
| 2024-12-03 | -0.30 |
| 2024-12-02 | -0.38 |
| 2024-11-29 | -0.40 |
| 2024-11-27 | -0.39 |
| 2024-11-26 | -0.39 |
| 2024-11-25 | -0.45 |
| 2024-11-22 | -0.47 |
| 2024-11-21 | -0.45 |
| 2024-11-20 | -0.46 |
| 2024-11-19 | -0.49 |
| 2024-11-18 | -0.50 |
| 2024-11-15 | -0.56 |
| 2024-11-14 | -0.60 |
| 2024-11-13 | -0.67 |
| 2024-11-12 | -0.71 |
| 2024-11-11 | -0.79 |
| 2024-11-08 | -0.73 |
| 2024-11-07 | -0.74 |
| 2024-11-06 | -0.79 |
| 2024-11-05 | -0.73 |
| 2024-11-04 | -0.64 |
| 2024-11-01 | -0.65 |
| 2024-10-31 | -0.64 |
| 2024-10-30 | -0.69 |
| 2024-10-29 | -0.72 |
| 2024-10-28 | -0.78 |
| 2024-10-25 | -0.75 |
| 2024-10-24 | -0.75 |
| 2024-10-23 | -0.76 |
| 2024-10-22 | -0.79 |
| 2024-10-21 | -0.96 |
| 2024-10-18 | -0.82 |
| 2024-10-17 | -0.80 |
| 2024-10-16 | -0.85 |
| 2024-10-15 | -0.82 |
| 2024-10-14 | -0.77 |
| 2024-10-11 | -0.75 |
| 2024-10-10 | -0.67 |
| 2024-10-09 | -0.73 |
| 2024-10-08 | -0.74 |
| 2024-10-07 | -0.76 |
| 2024-10-04 | -0.82 |
| 2024-10-03 | -0.76 |
| 2024-10-02 | -0.76 |
| 2024-10-01 | -0.78 |
| 2024-09-30 | -0.83 |
| 2024-09-27 | -0.86 |